Ken Griffin Retractable Technologies Inc Call Options Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2025 May 15, 2025	BUY	$0.7 - $0.85 $8,119 - $9,860	11,600 Added 297.44%	15,500 $10,000
Q4 2024 Feb 14, 2025	BUY	$0.57 - $0.79 $683 - $948	1,200 Added 44.44%	3,900 $2,000
Q3 2024 Nov 14, 2024	SELL	$0.72 - $1.19 $936 - $1,547	-1,300 Reduced 32.5%	2,700 $2,000
Q2 2024 Aug 14, 2024	BUY	$0.91 - $1.18 $2,548 - $3,304	2,800 Added 233.33%	4,000 $4,000
Q1 2024 May 15, 2024	SELL	$1.08 - $1.34 $7,128 - $8,844	-6,600 Reduced 84.62%	1,200 $1,000
Q4 2023 Feb 14, 2024	SELL	$0.97 - $1.21 $1,164 - $1,452	-1,200 Reduced 13.33%	7,800 $8,000
Q3 2023 Nov 14, 2023	SELL	$1.09 - $1.29 $545 - $645	-500 Reduced 5.26%	9,000 $10,000
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.89 $728 - $1,323	-700 Reduced 6.86%	9,500 $10,000
Q1 2023 May 15, 2023	SELL	$1.65 - $2.03 $2,145 - $2,638	-1,300 Reduced 11.3%	10,200 $17,000
Q4 2022 Feb 14, 2023	SELL	$1.64 - $2.48 $820 - $1,240	-500 Reduced 4.17%	11,500 $18,000
Q3 2022 Nov 14, 2022	BUY	$1.92 - $5.04 $23,040 - $60,480	12,000 New	12,000 $24,000

2.31M

15.5K

200

Ticker RVP
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 32,937,200
Market Cap $24.7M
Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.